These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin. Marchetti M; Ammendolia MG; Superti F Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197 [TBL] [Abstract][Full Text] [Related]
25. Molecular basis for resistance of herpes simplex virus type 1 mutants to the sulfated oligosaccharide inhibitor PI-88. Ekblad M; Adamiak B; Bergefall K; Nenonen H; Roth A; Bergstrom T; Ferro V; Trybala E Virology; 2007 Oct; 367(2):244-52. PubMed ID: 17604805 [TBL] [Abstract][Full Text] [Related]
26. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. Laquerre S; Argnani R; Anderson DB; Zucchini S; Manservigi R; Glorioso JC J Virol; 1998 Jul; 72(7):6119-30. PubMed ID: 9621076 [TBL] [Abstract][Full Text] [Related]
27. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors. Jenssen H; Gutteberg TJ; Lejon T J Pept Sci; 2005 Feb; 11(2):97-103. PubMed ID: 15635641 [TBL] [Abstract][Full Text] [Related]
28. [Biological properties of hemagglutinin of herpes simplex virus type 1]. Yoshida T Fukuoka Igaku Zasshi; 1994 Mar; 85(3):91-100. PubMed ID: 8175105 [TBL] [Abstract][Full Text] [Related]
29. Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion. Gianni T; Fato R; Bergamini C; Lenaz G; Campadelli-Fiume G J Virol; 2006 Aug; 80(16):8190-8. PubMed ID: 16873275 [TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface. Kato A; Arii J; Shiratori I; Akashi H; Arase H; Kawaguchi Y J Virol; 2009 Jan; 83(1):250-61. PubMed ID: 18945776 [TBL] [Abstract][Full Text] [Related]
31. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells. Ammendolia MG; Marchetti M; Superti F Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064 [TBL] [Abstract][Full Text] [Related]
33. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Chien YJ; Chen WJ; Hsu WL; Chiou SS Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695 [TBL] [Abstract][Full Text] [Related]
34. The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules. Galdiero S; Vitiello M; D'Isanto M; Falanga A; Cantisani M; Browne H; Pedone C; Galdiero M Chembiochem; 2008 Mar; 9(5):758-67. PubMed ID: 18311743 [TBL] [Abstract][Full Text] [Related]
35. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013 [TBL] [Abstract][Full Text] [Related]
36. Targeting HSV amplicon vectors. Grandi P; Spear M; Breakefield XO; Wang S Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173 [TBL] [Abstract][Full Text] [Related]
37. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636 [TBL] [Abstract][Full Text] [Related]
38. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275 [TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. Mårdberg K; Trybala E; Glorioso JC; Bergström T J Gen Virol; 2001 Aug; 82(Pt 8):1941-1950. PubMed ID: 11458001 [TBL] [Abstract][Full Text] [Related]
40. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. Herold BC; Gerber SI; Belval BJ; Siston AM; Shulman N J Virol; 1996 Jun; 70(6):3461-9. PubMed ID: 8648678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]